Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
The medical device industry is growing, at a healthy and steady pace. This is according to EY’s Pulse of the Industry report, which was released today at AdvaMed’s annual Medtech Conference.
“The results of this year’s report is a direct contrast to last year and tells a positive story about the future of the medtech industry,” said EY partner Arda Ural. Read more
DeviceTalks Boston on Oct 2. will give attendees the chance to see some of the best minds in medtech live. There will be learning and networking opportunities galore.
Read on and meet some of the top medical device leaders and experts who will be speaking – and discover other highlights from the upcoming show. Read more
Every year, more than 1 million patients in the U.S. find themselves suffering from respiratory complications following surgery, according to Hill-Rom.
These complications come at a cost – to both the patient and the hospital. A respiratory problem can increase a patient’s time in the hospital by as much as 89%. More people die each year from pulmonary complications than from breast cancer, the Chicago-based company reported. Read more
Boston Scientific launched today its Resonate implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator systems with the HeartLogic heart failure diagnostic tool.
The devices are approved by the FDA for conditional use in an MRI environment, the company reported. Read more
Shandong Weigao Group Medical Polymer agreed to pay $850 million for Argon Medical Devices, as the Chinese company looks to expand its footprint overseas.
Weigao Group, which makes medical devices, orthopedic and blood purification products, is trying to fill out its product portfolio and diversify its revenue stream, according to a filing with the Hong Kong Stock Exchange. The company said it expects “significant growth opportunities” for Argon Medical’s products in China, according to the filing. Read more